Cargando…
Mantle cell lymphoma and its management: where are we now?
Mantle cell lymphoma is a relatively new recognized hematological malignant disease, comprising of 2.5–6% non-Hodgkin’s lymphomas. The complexity of its clinical presentations (nodular pattern, diffuse pattern, and blastoid variant), variety in disease progression, and treatment response, make this...
Autores principales: | Ladha, Abdullah, Zhao, Jianzhi, Epner, Elliot M., Pu, Jeffrey J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6354396/ https://www.ncbi.nlm.nih.gov/pubmed/30733891 http://dx.doi.org/10.1186/s40164-019-0126-0 |
Ejemplares similares
-
Mantle cell lymphoma management trends and novel agents: where are we
going?
por: Pu, Jeffrey J., et al.
Publicado: (2022) -
Onchodermatitis: Where Are We Now?
por: Murdoch, Michele E.
Publicado: (2018) -
CAR-T cell therapy: Where are we now, and where are we heading?
por: Wang, Jia-Yi, et al.
Publicado: (2023) -
Liquid Biopsy in the Management of Breast Cancer Patients: Where Are We Now and Where Are We Going
por: Mazzitelli, Carlotta, et al.
Publicado: (2023) -
Where are we now and where are we headed?
por: Langan, Ewan A.
Publicado: (2023)